Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy

NCT04588909 | Unknown

• 1 other identifier: 73/2020 (Supl 2)
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Due to COVID 19 (Corona virus disease)pandemic, majority of surgeries, including surgery for cancer patients got delayed across the globe. Surgeries were limited to emergency set up only. At our institute we tried to perform colorectal cancer surgeries through out the pandemic, albeit in less numbers, as we thought cancer in itself is an emergency setting. we are planning to analyse the prospectively managed database of this particular group of patients over a period of last six 6 months and look out at 30 day post operative morbidity and mortality. Besides we will try to analyse the implications of our decision to carry on with cancer surgeries in terms of number of health care workers who got infected while being involved in primary care of these patients.

Conditions

Colo-rectal Cancer

Keywords

colorectal cancer; COVID 19 pandemic

Outcome Measures

Primary Outcomes (1)

• Early post operative mortality

  patients who died within 30 days following their surgery

  30 days

Secondary Outcomes (3)

• Early Post operative complications

  30 days

• Incidence of SARS CoV2 infectivity among health care providers providing direct care to involved patients

  30 days

• Rate of hospital acquired SARS CoV 2 infection among operated patients.

  30 days

Interventions

Colorectal resections PROCEDURE

All patients admitted with colorectal cancer were subjected to various types of colorectal resections

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All Colorectal cancer patients subjected to both elective and emergency surgery during COVID 19 pandemic.

You may qualify if:

• colorectal cancer patients subjected to surgery during COVID 19 pandemic

You may not qualify if:

• SARS CoV 2 infected patients

Sponsors & Collaborators

• Sheri Kashmir Institute of Medical Sciences: lead

Study Sites (1)

Sher i Kashmir Institute of Medical Sciences

Srinagar, Jammu and Kashmir, 190011, India

Location

MeSH Terms

Conditions

Colonic Neoplasms; Colorectal Neoplasms; COVID-19

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Nisar A Chowdri

  Government organisation

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Resident

Study Record Dates

• First Submitted: October 14, 2020
• First Posted: October 19, 2020
• Study Start: March 23, 2020
• Primary Completion: September 22, 2020
• Study Completion: October 22, 2020
• Last Updated: October 19, 2020

Record last verified: 2020-10

Data Sharing

• IPD Sharing: Will not share

Locations

IN (1)